Squamous cell carcinoma of the rectum: a consequence of immunosuppression resulting from inhibiting tumour necrosis factor (TNF)?

Silverton, Alexandra; Raad, Roy A; Katz, Leah; Downey, Andrea; Muggia, Franco M

Silverton, Alexandra; Raad, Roy A; Katz, Leah; Downey, Andrea; Muggia, Franco M.

Afiliación

Silverton A; Department of Medicine, Perlmutter Cancer Center at the New York University Langone Medical Center, New York, NY 10016, USA.
Raad RA; Department of Radiology, Perlmutter Cancer Center at the New York University Langone Medical Center, New York, NY 10016, USA.
Katz L; Department of Radiation Oncology, Perlmutter Cancer Center at the New York University Langone Medical Center, New York, NY 10016, USA.
Downey A; Department of Medicine, Perlmutter Cancer Center at the New York University Langone Medical Center, New York, NY 10016, USA.
Muggia FM; Department of Medicine, Perlmutter Cancer Center at the New York University Langone Medical Center, New York, NY 10016, USA.

Ecancermedicalscience ; 10: 646, 2016.

Article en En | MEDLINE | ID: mdl-27350791

Palabras clave

TNF antagonists; etanercept; rectal cancer; rheumatoid arthritis; secondary malignancies; squamous cell cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ecancermedicalscience Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google